Trial intelligence / Profile preview

Statins Combined With Hybutimibe in Acute Ischemic Stroke or TIA

NCT07908875Phase 3Not yet recruiting

Sponsor
Yejishan Hospital of Wannan Medical College
Start
Nov 2026
Primary completion
Sep 2027
01

Overview

A Phase 3 trial of hybutimibe in ischemic stroke, Transient Ischemic Attack (TIA), sponsored by Yejishan Hospital of Wannan Medical College. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

hybutimibe
03

Conditions

ischemic strokeTransient Ischemic Attack (TIA)

Beyond the preview

Go deeper on NCT07908875.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07908875.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call